Galderma

Galderma, founded in 1981, is a global dermatology company dedicated exclusively to skin health. It operates across three primary business areas: injectable aesthetics, dermatological skincare, and therapeutic dermatology. The company leverages scientific innovation to develop and market a comprehensive portfolio of products and treatments designed to address both cosmetic and medical skin conditions. With a strong commitment to science-based care, Galderma partners closely with healthcare professionals worldwide to deliver tailored solutions for individual skin needs, spanning daily skincare routines to advanced prescription therapies.

Employing between 5,000 and 10,000 individuals, Galderma maintains a significant global footprint with operations in 19 locations worldwide. This extensive network allows the company to serve diverse markets and patient populations effectively. The organization's scale and reach are supported by a dedicated team focused on advancing dermatological science and patient care. Meet Galderma's team to learn more about the professionals driving its mission. Their international presence underscores a commitment to making advanced dermatological solutions accessible globally.

Galderma's product offerings include well-known brands and prescription treatments that cover the full spectrum of skin health needs. From iconic skincare lines like Cetaphil to sophisticated aesthetic injectables and essential therapeutic dermatology treatments, the company addresses conditions ranging from acne and rosacea to aging and skin cancer. This broad approach, combined with a heritage rooted in dermatological research, positions Galderma as a leader in advancing skin health for individuals at every stage of life, ensuring science-driven care is at the forefront of their offerings.